Court Consolidates Takeda Antitrust Suits Over IBS Drug
By Piper Hudspeth Blackburn · January 23, 2023, 6:44 PM EST
A Massachusetts federal judge on Monday consolidated a pair of proposed class actions alleging that Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal to keep a generic version of...
To view the full article, register now.